全文获取类型
收费全文 | 389篇 |
免费 | 28篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 17篇 |
妇产科学 | 11篇 |
基础医学 | 15篇 |
口腔科学 | 5篇 |
临床医学 | 70篇 |
内科学 | 146篇 |
皮肤病学 | 35篇 |
神经病学 | 6篇 |
特种医学 | 16篇 |
外科学 | 40篇 |
综合类 | 14篇 |
一般理论 | 3篇 |
预防医学 | 17篇 |
眼科学 | 2篇 |
药学 | 17篇 |
肿瘤学 | 8篇 |
出版年
2017年 | 8篇 |
2016年 | 9篇 |
2015年 | 11篇 |
2014年 | 18篇 |
2013年 | 15篇 |
2011年 | 6篇 |
2010年 | 21篇 |
2009年 | 13篇 |
2006年 | 5篇 |
1997年 | 5篇 |
1996年 | 10篇 |
1995年 | 10篇 |
1994年 | 13篇 |
1993年 | 6篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 13篇 |
1988年 | 5篇 |
1987年 | 5篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 9篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 6篇 |
1974年 | 8篇 |
1972年 | 4篇 |
1971年 | 7篇 |
1970年 | 3篇 |
1969年 | 4篇 |
1968年 | 3篇 |
1966年 | 3篇 |
1965年 | 4篇 |
1964年 | 9篇 |
1963年 | 5篇 |
1961年 | 3篇 |
1959年 | 3篇 |
1958年 | 15篇 |
1957年 | 13篇 |
1956年 | 4篇 |
1955年 | 14篇 |
1954年 | 7篇 |
1948年 | 8篇 |
排序方式: 共有423条查询结果,搜索用时 0 毫秒
421.
JO JO HAI M.B.B.S. CHRISTOPHER V. DESIMONE M.D. Ph.D. VAIBHAV R. VAIDYA SAMUEL J. ASIRVATHAM M.D. 《Journal of cardiovascular electrophysiology》2014,25(1):94-98
Catheter ablation is an increasingly used and successful treatment choice for right ventricular outflow tract (RVOT) arrhythmias. While the role of endocavitary structures and the regional morphology of the ventricular inflow tract and the right atrium as a cause for difficulty with successful ablation are well described, similar issues within the RVOT are not well understood. It is also not commonly appreciated that one of the papillary muscles is located within the proximal RVOT. We report 3 patients in which ventricular arrhythmia was targeted and ablated in the conus papillary muscle. The anatomic features, potential role of the fascicular conduction system, and unique challenges with mapping arrhythmia arising from this structure are discussed. 相似文献
422.
Electrophysiologic Characteristics of Ventricular Arrhythmias Arising from the Aortic Mitral Continuity—Potential Role of the Conduction System 下载免费PDF全文
JO JO HAI M.B.B.S. ANWAR A. CHAHAL M.B.Ch.B. PAUL A. FRIEDMAN M.D. VAIBHAV R. VAIDYA M.B.B.S. FAISAL F. SYED M.B.Ch.B. CHRISTOPHER V. DeSIMONE M.D. Ph.D. SUDIP NANDA M.D. PETER A. BRADY M.B.Ch.B. M.D. MALINI MADHAVAN M.D. YONG‐MEI CHA M.D. CHRISTOPHER J. McLEOD M.B.Ch.B. Ph.D. SIVA MULPURU M.D. THOMAS M. MUNGER M.D. DOUGLAS L. PACKER M.D. SAMUEL J. ASIRVATHAM M.D. 《Journal of cardiovascular electrophysiology》2015,26(2):158-163
423.
SAMUEL LÉVY M.D. PHILIPPE RICHARD M.D. 《Journal of cardiovascular electrophysiology》1994,5(11):982-985
ICD for Treatment of AF. The experience gained using intracardiac cardioverter defibrillators for the treatment of ventricular arrhythmias has prompted the development of an automatic atrial defibrillator capable of detecting and automatically terminating atrial fibrillation (AF). Experimental studies in sheep have shown that it is possible to terminate AF with energies ranging from < 1 to 7 joules [J], using biphasic shocks. The best electrode configuration using intracardiac catheters and/or a subcutaneous patch was two catheters, one in the right atrium and the other in the coronary sinus. Current studies in man focus on the answers to three questions. First, can the experimental results of atrial defibrillation derived from healthy anesthetized sheep without spontaneous AF be extrapolated to AF in man with areas of fibrosis within the atria and/or underlying heart disease in 80% of cases? Preliminary studies in man suggest that cardioversion of AF of short duration is feasible using a mean energy of 2 J. Second, are these energies well tolerated in an awake nonsedated patient? Energies < 1 J were well tolerated, but pain resulting from higher energies needs further investigation. Third, is low-energy atrial defibrillation safe, i.e., is there a risk of ventricular arrhythmias induced by an atrial shock? Experimental results in sheep have shown that the risk of R wave synchronized shock to induce ventricular arrhythmias was only present when the preceding RR interval was shorter than 300 msec. The risk of proarrhythmia in man is undergoing evaluation and must be sufficiently low (< 0.1) before sanctioning implantation of a stand-alone (without associated ventricular defibrillator) automatic atrial defibrillator. Preliminary data on 1212 shocks showed no proarrhythmia. There is definitely a significant group of patients with attacks of AF (Class IIIB or IIIC) that are resistant to antiar-rhythmic therapy. Another group of symptomatic patients may have infrequent attacks, or poorly tolerated (syncope or heart failure) or long-lasting attacks requiring medical intervention and/or hospitalization (Class IB, IIB), for whom an automatic atrial defibrillator may be a valuable option. The alternative therapies could be either catheter ablation of the AV node with implantation of a pacemaker or selective surgery. Most of the technical problems related to AF detection and reliable atrial defibrillation have been solved. However, clinical investigations are needed to evaluate the efficacy and safety of this new and exciting therapeutic modality. 相似文献